In a study published in the journal Annals of Surgery, researchers report that breast cancer patients surveyed about their knowledge of breast reconstruction were only moderately informed about the procedure, and their knowledge of complications was low.
With only one physician in Malawi trained to perform the surgical procedure required to treat cervical cancer—radical hysterectomy—women died in large numbers from the disease. Two UNC OB-GYNs came up with a way to change that.
Ten-year-old Ellie Stewart was diagnosed with choriocarcinoma in February. Her only plans for the summer were to finish her chemotherapy treatment at N.C. Children’s Hospital. Then she received a surprise gift: tickets to attend Taylor Swift’s June 9 concert in Raleigh. Now Ellie has some...
Two new faculty members have joined the UNC Lineberger Comprehensive Cancer Center to help launch groundbreaking immunotherapy clinical trials that will test an experimental treatment in which patients’ own immune cells are genetically engineered to fight their cancer.
The latest installment in our Real Medicine video series features one of our Patient Ambassadors for North Carolina Children's Hospital.
Device that drives drugs into solid tumors that are poorly vascularized opens the possibility of life-saving surgeries in cancer patients. James Byrne, PhD, a medical student and member of Joseph DeSimone’s lab, led the research by constructing the device and examining its ability to deliver chemotherapeutic drugs effectively to pancreatic cancer tumors, as well as two types of breast cancer tumors.
Carolina legend Danny Talbott performed at the highest level on both the football field and baseball diamond during his years as a Tar Heel. Since 2010, he’s been back in Chapel Hill, battling the toughest opponent he’s faced: multiple myeloma. He can’t imagine going anywhere else to do it.
Researchers from the UNC/NCSU Joint Department of Biomedical Engineering developed nanoparticles that could deliver cancer therapies in a safer and more effective way.
The cost of insurance co-payments for cutting-edge pharmaceuticals can vary widely from patient to patient. When the patient’s share of prescription costs becomes too high, many patients skip doses or stop taking medication entirely, according to research conducted at the University of North Carolina.
The probe, named UNC1215, will provide researchers with a powerful tool to investigate the function of malignant brain tumor (MBT) domain proteins in biology and disease.
Research from the University of North Carolina at Chapel Hill suggests that the timing of exposure to UV rays – early in the morning or later in the afternoon – can influence the onset of skin cancer.
